The analyst price target for Tandem Diabetes Care, Inc. (TNDM) is 24% lower than the estimated fair value. Using a Discounted Cash Flow (DCF) model, the company's future cash flows are projected and discounted to determine its investment potential.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing